Bromantane
Bromantane (also researched as Ladasten or ADK-709) is a synthetic adamantane derivative characterized in scientific literature as an actoprotector. Distinct from classical psychostimulants, Bromantane is highly valued in neurochemical research due to its non-receptor-mediated, transcriptional mechanism of action. Rather than forcing the rapid release of existing neurotransmitter pools or blocking reuptake channels, it acts on gene expression pathways to upregulate the cellular machinery responsible for dopamine biosynthesis. This unique profile makes it an essential tool for investigators studying the metabolic and transcriptional regulation of dopaminergic pathways.
Technical Specifications
| Property | Specification |
| Product Name | Bromantane (Ladasten) |
| CAS Number | 87913-26-6 |
| IUPAC Name | N-(4-bromophenyl)adamantan-2-amine |
| Molecular Formula | C₁₆H₂₀BrN |
| Molecular Weight | 306.24 g/mol |
| Chemical Class | Adamantane derivative |
| Assay Purity | Verified via HPLC-UV & MS |
Research Applications & Mechanism of Interest
The primary academic interest in Bromantane lies in its novel transcriptional influence on catecholamine biosynthesis. Research published in Neuroscience and Behavioral Physiology demonstrates that the compound’s effects are mediated through the genomic upregulation of critical dopaminergic enzymes rather than direct receptor interaction.
Primary fields of investigative research include:
-
Upregulation of Biosynthetic Enzymes: Evaluating how the compound stimulates the expression of tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC)—the rate-limiting and terminal enzymes, respectively, in the synthesis of dopamine.
-
Transporter Pharmacology Comparison: Serving as a crucial negative control in transport essays. Because Bromantane lacks functional affinity for the dopamine transporter (DAT), researchers utilize it to isolate transcriptional synthesis changes from synaptic reuptake inhibition.
-
Transcriptional Kinetics: Mapping the prolonged molecular timescale of gene-expression-mediated monoamine regulation (occurring over hours) compared to the millisecond-range synaptic transmission changes triggered by traditional stimulants.
-
Anti-Doping & Forensic Assays: Due to its classification by the World Anti-Doping Agency (WADA) under class S6.A (Non-Specified Stimulants), Bromantane is highly relevant to sports science. Investigators deploy it as a primary reference standard for developing, validating, and calibrating doping-control detection methodologies.
Storage & Handling Guidelines
To preserve structural integrity and prevent the chemical degradation of this halogenated adamantane derivative during laboratory handling:
-
Temperature Maintenance: Store the compound continuously in a cool, dry environment.
-
Atmospheric Protection: Keep the container tightly sealed inside an airtight environment to completely isolate the material from ambient moisture and humidity.
-
Photolytic Safeguards: Protect the compound from direct exposure to light and ultraviolet (UV) radiation by storing it inside opaque or amber laboratory vessels.
-
Analytical Quality Assurance: Kimera Chems verifies the identity and purity profile of every lot using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) against certified reference standards to ensure absolute experimental reproducibility.
Research Use Only Disclaimer: This product is distributed and sold strictly as a Research Use Only (RUO) analytical standard. It is not an FDA-approved drug, licensed medication, food product, cosmetic, or dietary supplement, and is strictly prohibited for human or veterinary use. Kimera Chems supplies these reference materials exclusively to qualified scientific institutions, anti-doping laboratories, and professional investigators for use within controlled in vitro and analytical testing frameworks.
Frequently Asked Research Questions
How does Bromantane’s dopamine-related mechanism differ from classical stimulants?
Traditional stimulants (such as amphetamine or methylphenidate) act directly on transport proteins to inhibit reuptake or force immediate neurotransmitter release. Bromantane operates via genomic pathways, upregulating the actual synthesis capacity of dopamine by increasing the expression of the rate-limiting enzymes tyrosine hydroxylase and AADC.
Is Bromantane soluble in aqueous laboratory assays?
No. Bromantane exhibits poor solubility in water. To prepare stable laboratory assays or calibration standards, it must be dissolved in organic solvents such as dimethyl sulfoxide (DMSO) before introduction to experimental buffers.
Scientific References
-
Morozov, I. S., Barchukov, V. G., & Neznamov, G. G. (1999). “Actoprotectors: a new class of drugs.” Pharmaceutical Chemistry Journal, 33(5), 235–238. DOI: 10.1007/BF02509930.
-
Salimov, R. M., et al. (2001). “The effects of ladasten on the levels of monoamines and their metabolites in the rat brain.” Neuroscience and Behavioral Physiology, 31(6), 613–619. DOI: 10.1023/A:1012351214352.
-
Grekhova, T. V., et al. (1995). “Effect of bromantane on the dopaminergic system of the rat brain.” Bulletin of Experimental Biology and Medicine, 119(3), 262–264. DOI: 10.1007/BF02445831.
| CAS Number | 87913-26-6 |
| Other Names | Bromantan, Ladasten, bromontan, UNII-N1ILS53XWK, N1ILS53XWK, SCHEMBL737152, CHEMBL4303520, DTXSID40405333, AKOS004120981, AKOS037644786, AS-54469 |
| IUPAC Name | N-(4-bromophenyl)adamantan-2-amine |
| Molecular Formula | C₁₆H₂₀BrN |
| Molecular Weight | 306.24 |
| Liquid Concentration And Solution | 100mg/ml (MCT Oil) |
| Aliquot Concentration And Solution | 100mg/ml Vial (MCT Oil, Benzyl Benzoate, Benzyl Alcohol) |






